Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AZITHROMYCIN Cause Transient ischaemic attack? 120 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 120 reports of Transient ischaemic attack have been filed in association with AZITHROMYCIN (AZITHROMYCIN). This represents 0.7% of all adverse event reports for AZITHROMYCIN.

120
Reports of Transient ischaemic attack with AZITHROMYCIN
0.7%
of all AZITHROMYCIN reports
12
Deaths
115
Hospitalizations

How Dangerous Is Transient ischaemic attack From AZITHROMYCIN?

Of the 120 reports, 12 (10.0%) resulted in death, 115 (95.8%) required hospitalization, and 8 (6.7%) were considered life-threatening.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AZITHROMYCIN. However, 120 reports have been filed with the FAERS database.

What Other Side Effects Does AZITHROMYCIN Cause?

Off label use (2,979) Drug ineffective (2,609) Drug hypersensitivity (1,978) Dyspnoea (1,409) Condition aggravated (1,063) Nausea (1,006) Asthma (972) Wheezing (951) Product use in unapproved indication (886) Cough (837)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454)

Which AZITHROMYCIN Alternatives Have Lower Transient ischaemic attack Risk?

AZITHROMYCIN vs AZITHROMYCIN ANHYDROUS AZITHROMYCIN vs AZITHROMYCIN OR METHOTREXATE AZITHROMYCIN vs AZOSEMIDE AZITHROMYCIN vs AZTREONAM AZITHROMYCIN vs AZTREONAM LYSINE

Related Pages

AZITHROMYCIN Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack AZITHROMYCIN Demographics